fbpx Skip to main content

News & Insights

Sign up to receive the latest news and insights straight to your inbox.

Featured Blog

Intratumoral Pressure: A Formidable Barrier to Effective Cancer Therapy

Here’s something you and your interventional radiologist colleagues may never have learned in medical school: The most potent state-of-the-art therapeutic option for defeating a solid tumor may not achieve the hoped-for result unless it is delivered by an equally advanced method of drug delivery — because otherwise it may not actually reach deep into the tumor.

Read Blog

7 Results

Dec. 14, 2023

TriSalus Life Sciences Announces CMS Reimbursement for the TriNav® Infusion System via Assignment of a New Technology Healthcare Common Procedure Coding System (HCPCS) Code

Mar. 1, 2023

Bridge therapy or tumor downstaging therapy and the TriNav® Infusion System may help patients reach their liver transplantation goals.

Feb. 1, 2023

Could delivering liver cancer treatment using the TriNav® Infusion System benefit your patients?

Jan. 10, 2023

SIO: Advancing the field of interventional oncology and related therapies, such as immunotherapy for liver cancer and pancreatic cancer.

Oct. 20, 2022

Intratumoral Pressure: A Formidable Barrier to Effective Cancer Therapy

Jan. 13, 2020

TriSalus™ Life Sciences Launches the new TriNav™ Infusion System, an Innovative Solution Designed to Overcome Infusion Barriers within Solid Tumors

Nov. 20, 2019

TriSalus™ Life Sciences’ Surefire® Spark™ Infusion System (TriNav™) Receives CMS Approval for Transitional Pass-Through Payment Status